PMS38 COST-EFFECTIVENESS OF RITUXIMAB VERSUS ALTERNATIVE ANTI-TUMOR NECROSIS FACTOR (TNF) THERAPY AFTER PREVIOUS FAILURE OF ONE ANTI-TNF AGENT FOR TREATMENT OF RHEUMATOID ARTHRITIS IN MEXICO
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)72191-X
https://www.valueinhealthjournal.com/article/S1098-3015(11)72191-X/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
350
First Page :
A309
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72191-X&doi=10.1016/S1098-3015(11)72191-X